Clinical Articles
1) MODLIN IM, Moss SF, Oberg K, Padbury R, Hicks R, Gustafsson BI, Wright NA, Kidd M. Gastrointestinal neuroendocrine (carcinoid) tumor - current diagnosis and management. Australian Medical Journal 2010 (accepted).
2) MODLIN IM, Pavel M, Kidd M, Gustafsson BI. Somatostatin analogues: An appraisal of their utility and efficacy. Aliment Pharmacol Ther (2009) (in press).
3) Klimstra D, MODLIN IM, Adsay N, Chetty R, Deshpande V, Gonen M, Jensen R, Kidd M, Kulke M, R. L, Moran C, Moss S, Oberg K, O’Toole D, Rindi G, Robert M, Suster S, Tang L, Tzen C-Y, Washington M, Wiedenmann B, Yao J. Pathologic Reporting of Neuroendocrine Tumors: Application of the Delphic Consensus Process to the Development of a Minimum Pathologic Data Set. Am J Pathol (2009) (in press).
4) MODLIN IM, Wright NA, Gustafsson BI, Kidd M. Gastrointestinal neuroendocrine (carcinoid) tumors. Gastroenterology (2009) (in press).
5) Kahrilas PJ, Shaheen NJ, Vaezi MF, Hiltz SW, Black E, MODLIN IM, Johnson SP, Allen J, Brill JV; American Gastroenterological Association. American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology. 2008 Oct;135(4):1383-1391, 1391.e1-5.
6) MODLIN IM, Hunt RH, Malfertheiner P, Moayyedi P, Quigley EM, Tytgat GN, Tack J, Holtmann G, Moss SF. Non-erosive reflux disease--defining the entity and delineating the management. Digestion. 2008;78 Suppl 1:1-5. Epub 2008 Oct 2.
7) Pannala R, Kidd M, MODLIN IM. Acute pancreatitis: the rapid pace of no change. Pancreas 2009;38:355-66.
8) MODLIN IM, Moss SF, Chung DC, Jensen RT, Snyderwine E. Priorities for improving management of gastropancreatic neuroendocrine tumors. J Natl Cancer Inst 2008; 100:1282-9.
9) Gustafsson BI, Siddique Z-L, Chan AK, Manku D, Drozdov I, Kidd M, MODLIN IM. Uncommon cancers of the small intestine, appendix and colon: An analysis of SEER 1973-2004, and current diagnosis and therapy. International Journal of Cancer 2008; 33:1121-31.
10) MODLIN IM, Kidd M, Drozdov I, Siddique Z-L, Gustafsson BI. Pharmacotherapy of Neuroendocrine Cancers. Expert Opinion on Pharmacotherapy 2008; 9:2617-26.
11) Hauso O, Gustafsson G, Kidd M, Waldum H, Drozdov I, Chan AK, MODLIN IM. Neuroendocrine Tumor Epidemiology: Contrasting Norway and North America. Cancer 2008; 113:2655-64.
12) Gustafsson BI, Hauso O, Drozdov I, Kidd M, MODLIN IM. Carcinoid Heart Disease. (International Journal of Cardiology (2008) (in press).
13) Bornschein J, Kidd M, Malfetheiner P, MODLIN IM. Neuroendokrine Tumoren des Gastrointestinaltraktes. Dtsch Med Wochenschr 2008;133: 1505-10.
14) Gustafsson BI, Kidd M, Chan A, Malfertheiner MV, MODLIN IM. Bronchopulmonary neuroendocrine tumors. Cancer 2008; 113:5-21.
15) MODLIN IM, Moss SF. Symptom Evaluation in Gastroesophageal Reflux Disease. J Clin Gastroenterol. 2008; 42:558-563.
16) Hungin P, MODLIN IM. NERD: a new approach in managing reflux symptoms. Fam Pract. 2008; 25:397-9.
17) MODLIN IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, Caplin M, Delle Fave G, Kaltsas GA, Krenning EP, Moss SF, Nilsson O, Rindi G, Salazar R, Ruszniewski P, Sundin A. Gastroenteropancreatic Neuroendocrine Tumors. Lancet Oncol 2008; 9:61-72.
18) Gustafsson BI, Kidd M, MODLIN IM. Neuroendocrine tumors of the Diffuse Neuroendocrine System. Current Opinion in Oncology 2008; 20:1-12.
19) MODLIN IM, Champaneria MC, Chan AKC, Kidd M. A three decade analysis of 3,911 small intestinal carcinoids: The rapid pace of no progress. Am J Gastroenterol 2007; 102: 1464-73.
20) Hunt RH, Tytgat G, Malfertheiner P, Fock KM, Heading R, Katelaris P, McCarthy D, McColl KE, Moss SF, Sachs G, Sontag SJ, Thomson A, MODLIN IM. Whistler Summary: “the slow rate of progress”. J. Clin Gastroenterol 2007; 41:539-45.
21) Moss SF, Kidd M, MODLIN IM. The status of the hiatus: the role of hernia in gastroesophageal reflux disease. J Clin Gastroenterol (2007) (in press).
22) Hunt RH, Malfertheiner P, Armstrong D, Holtmann G, Quigley EMM, Spechler SJ, MODLIN IM. GERD Evaluation – Time for a new paradigm. J Clin Gastroenterol 2007; 41:237-41.
23) Pannala R, Gafni-Kane A, Kidd M, MODLIN IM. An Ileal Endometrioma: Of Carcinoids and Cadherin. J Gastrointestinal Surgery 2007; 11:229-32.
24) MODLIN IM, Shapiro MD, Kidd M. Primary carcinoid tumor of the parotid: a case report and review of the literature. Ear Nose Throat Journal 2006; 85:533-9.
25) Latich I, MODLIN IM, Zikusoka MN, Kidd M, Eick G, Chan A. Gastrointestinal carcinoids – the Evolution of Diagnostic strategies. J Clin Gastroenterol 2006; 40:572-82.
26) MODLIN IM, Latich I, Kidd M, Zikusoka MN, Eick G. Therapeutic options for Gastrointestinal carcinoids. Clinical Gastroenterology and Hepatology 2006; 4:526-47.
27) Pannala R, Kidd M, MODLIN IM. Surgery for the Obese: A Panacea? Digestive Surgery 2006; 23:1-11.
28) Malfertheiner P, Fass R, Quigley EM, MODLIN IM, Malagelada JR, Moss SF, Holtmann G, Goh KL, Katelaris P, Stanghellini V, Talley NJ, Tytgat GN, Wright NA. Review article: from gastrin to gastro-oesophageal reflux disease--a century of acid suppression. Aliment Pharmacol Ther. 2006 Mar 15;23(6):683-90
29) Ballantyne GH, Gumbs A, MODLIN IM. Changes in insulin resistance following bariatric surgery and the adipoinsular axis: role of the adipocytokines, leptin, adiponectin and resistin. Obes Surg. 2005 May;15(5):692-9.
30) Gumbs AA, MODLIN IM, Ballantyne GH. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg. 2005 Apr;15(4):462-73.
31) MODLIN IM, Adler G, Alexander K, Arnold R, Brenner DA, Corazziari E, Floch MH, LaPorte RE, Peterson WL, Quigley EM, Shapiro MD, Spechler SJ, Spiller RC, Tytgat GN, Wiegers W. Information assimilation and distribution challenges and goals for real and virtual journals. J Clin Gastroenterol. 2005; 39: 181-8.
32) MODLIN IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current status of Gastrointestinal carcinoids. Gastroenterology 2005; 128: 1717-51.
33) Buragas M, Kidd M, MODLIN IM, Cha C. Multiple gastrointestinal stromal tumors and synchronous ileal carcinoid. Nature Medicine Clinical Practice 2005; 2(3): 1-5.
34) MODLIN IM, Shapiro MD, Kidd M. A Miscellany of rare carcinoids - Clarifying the clinical conundrum. World J. Surg 2005; 29:92-101.
35) MODLIN IM, Shapiro MD, Kidd M. Carcinoid tumors and fibrosis: a relation with little explanation. Am J Gastro 2004; 99:2466-2478.
36) MODLIN IM, Kidd M. GERD 2003: Issues from the past and a consensus for the future. Best Practice & Research Clinical Gastroenterology 2004; 18 Suppl: 55-66.
37) Mullerpatan PM, Joshi SR, Shah RC, Tampi CS, Doctor VM, Jagannath P, MODLIN IM. Calcitonin-secreting tumor of the pancreas. Dig Surg 2004; 21:321-324.
38) Abir F, MODLIN IM, Kidd M, Bell R. The Surgical Treatment of Achalasia: Current Status and Controversies. Digestive Surgery 2004; 21:165-176.
39) MODLIN IM, Moss SF, M Kidd, K Lye. Gastro-Esophageal Reflux Disease - Then and Now. J Clin Gastroenterol, 2004; 38:390-402.
40) MODLIN IM, Kidd M. GERD 2003: Issues from the past and a consensus for the future. Drugs Today 2004; 40(Suppl 1A) 3-8.
41) MODLIN IM, Lye K, Kidd M. Multiple gastric carcinoids. J Am Coll Surg 2004; 198: 174.
42) MODLIN IM, Lye K, Kidd M. A 50-year analysis of 562 gastric carcinoids: small tumor - or larger problem? Am J Gastroenterol 2004; 99: 23-32.
43) Koelz HR, Blum AL, MODLIN IM. Costs of GERD: Facts and Fiction. (Selected Summary) Gastroenterology 2003; 125: 981-2.
44) MODLIN IM, Kidd M, Lye K. Carcinoid Tumors of the Stomach. Surgical Oncology 2003; 12:153-172.
45) Moss SF, Armstrong D, Arnold R, Ferenci P, Fock KM, Holtmann G, McCarthy DM, Moraes-Filho JP, Mutschler E, Playford R, Spechler SJ, Stanghellini V, MODLIN IM. GERD 2003 - A Consensus on the Way Ahead. Digestion. 2003;67(3):111-7.
46) MODLIN IM, Kidd M, Lye KD, Murren J, Argiris A. Molecular Strategies and 111In-labeled somatostatin analogues in defining the management of neuroendocrine tumour disease: a new paradigm for surgical management. The Surgeon 2003; 1(3): 137-143.
47) MODLIN IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003; 97:934-959.
48) Gumbs AA, Moore PS, Falconi M, Bassi C, Beghelli S, MODLIN IM, Scarpa A. Review of the clinical, histological, and molecular aspects of pancreatic endocrine neoplasms. J Surg Oncol. 2002; 81:45-53.
49) Moss SF, MODLIN IM. Summation: irritable bowel and the irritable physician. J Clin Gastroenterol. 2002; 35 (1 Suppl):S68-70.
50) MODLIN IM. Efficacy and safety of intravenously administered pantoprazole in the treatment of gastrinoma. Recenti Prog Med 2001; 92:456-461.
51) Lew EA, Pisegna JR, Starr JA, Soffer EF, Forsmark C, MODLIN IM, Walsh JH, Beg M, Bochenek W, Metz DC. Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. Gastroenterol 2000; 118:696-704.
52) Yale University Workshop Reports. Extraesophageal Manifestations of Gastroesophageal Reflux Disease. J Clin Gastroenterol 2000:30 (3) (suppl).
53) MODLIN IM, Tang LH. Cell and tumour biology of the gastric enterochromaffin-like cell. Ital J Gastroenterol Hepato 1999:31(supp2):S117-30.
54) MODLIN IM, Tang LH, Svennevik. Gastric Carcinoid Tumors. Surgical Endocrinology, 2001, 30:431-446.
55) Schonfeld WH, Eiken EP, Woltering EA, MODLIN IM, Anthony L, Villa KF, Zagari M. The cost-effectiveness of octreotide acetate in the treatment of carcinoid syndrome and VIPoma. Int J Technol Assess Health Care 1998; 14:514-525
56) Sandor A, MODLIN IM. A retrospective analysis of 1570 appendiceal carcinoids. Am J Gastreoterol 1998; 93:422-428
57) Moss SF, Fendrick AM, Cave DR, MODLIN IM. Helicobacter pylori - more light, less heat? Am J Gastroenterol 1998; 93:306-310
58) MODLIN IM, Sandor A, Tang LH, Kidd M, Zelterman D. A 40 year analysis of 265 gastric carcinoids. Am J Gastroenterol 1997; 92: 633-638
59) Begos DG, Sandor A, MODLIN IM. The Diagnosis and Management of Adult Intussusception. Am J Surg 1997, 173: 88-94
60) MODLIN IM, Tang LH. Approaches to the diagnosis of Gut neuroendocrine tumors: The last word (Today). Gastroenterol 1997, 112: 583-590
61) MODLIN IM, Sandor A. An analysis of 8305 Cases of Carcinoid Tumors. Cancer 1997, 79:813-829
62) MODLIN IM, Gilligan CJ, Lawton GP, Tang LH, West AB, Lindenberg R. Observations on relationship between hypergastrinemia, multiple gastric carcinoids, and pancreatic mass. Dig Dis Sci 1996; 41(1):105.14.
63) MODLIN IM, Lawton GP, Cornelius E. Use of an Isotopic Somatostatin Receptor Probe to Image Gut Endocrine Tumors. Arch Surg 1995;130:367-374.
64) MODLIN IM, Gilligan CJ, Lawton GP, Tang LH, West AB, Darr U. Gastric Carcinoids: The Yale Experience. Arch Surg 1995; 130 (3) 250-256.
65) MODLIN IM. To Repair the Fault or End the Acid Reign? Scand J Gastroenterol 1995; 30 Suppl 210:1-5.
66) MODLIN IM and Hunt RH. Critical Reappraisal of Mucosal Repair Mechanisms. Scand J Gastroenterol 1995; 30 Suppl 210: 28-31.
67) Begos DG, Franco KL, Baldwin JC, Lee FA, Revkin JH, MODLIN IM. Optimal Timing And Indications For Cholecystectomy In Cardiac Transplant Patients. World J Surg. 19, 661-667, 1995.
68) Gilligan CJ, Tang LH, Lawton GP, West AB, MODLIN IM. Gastric Carcinoid Tumors: The Biology and Therapy of an Enigmatic and Controversial Lesion. Am J Gastro 1995;Vol. 90 (3):338-352.
69) Sgambati SA, Lawton GP, MODLIN IM. Chronic Pancreatitis: A Precursor to Pancreatic Carcinoma? Dig Surg 1994; 11:275-285.
70) Begos DG, MODLIN IM. Laparoscopic Cholecystectomy: From Gimmick To Gold Standard. J Clin Gastroenterol 1994; 19(4):325-30.
71) MODLIN IM, Lawton GP. Editorial: Duodenal Gastrinoma: The Solution to the Pancreatic Paradox. J Clin Gastroenterol 1994; 19(3):184-8.
72) Mani S, MODLIN IM, Ballantyne G, Ahlman H, West B. Carcinoids of the Rectum. Jo Am Coll Surg 1994, 179; 231-248.
73) MODLIN IM, Lawton FP. The Evolving Clinical Uses of Octreotide. Drug Therapy, August 1994; 28-38.
74) Lawton GP, MODLIN IM. Recent advances in the localization and surgical management of duodenal gatrinomas. In: Current Opinion in General Surgery 1994: 131-137, ed JM Daly, Current Science.
75) Ginsberg RJ, Miller TA, MODLIN IM. Esophageal, gastric and small intestine (editorial overview). In: Current Opinion in General Surgery 1994: 109-112, ed JM Daly, Current Science.
76) MODLIN IM, Goldenring JR, Lawton GP, Hunt R. Aspects of the Theoretical
77) Basis and Clinical Relevance of Low Acid States. Am J Gastro 1994;89(3):308-18.
78) Begos DG, MODLIN IM. Editorial: Gastrin and Colon Cancer Clarifying the Controversy. J Clin Gastro 1994; 18(3):189-93.
79) Leach SD, MODLIN IM, Goldstein L, Ballantyne GH. Laparoscopic Local Excision of a Proximal Rectal Carcinoid. J Laparoendosc Surg, Vol. 4 (1), 1994; 65-70.
80) MODLIN IM, Lewis JL, Kumar RR, Bilchik AJ, Ahlman H. Management of unresectable malignant endocrine tumors of the pancreas. Surg Gynecol Obstet 1993; 176:507-518.
81) Basson MD, Ahlman H, Wangberg B, MODLIN IM. Biology and management of the midgut carcinoid. Am J Surg 1993; 165:288-297.
82) Hurst RD, MODLIN IM. The use of radiolabeled somatostatin analogs in the identification and treatment of somatostatin receptor bearing tumors. Digestion 1993; 54(suppl):88-91.
83) MODLIN IM, Stoch SA, Soybel DI, Nilsson A, Ahlman H. Biological markers of neuroendocrine tumors of the gastrointestinal tract and pancreas. Eur J Surg 1992; 157:629-645.
84) Havlik RJ, Fried I, Chyatte D, MODLIN IM. Encephalo-Omental synangiosis in the management of moyamoya disease. Surgery 1992; 111(2):156-162.
85) Yapp R, MODLIN IM, Kumar RR, Binder HJ, Dubrow R. Gastrin and colorectal cancer: evidence against an association. Dig Dis and Sci 1992; 37(4):481-484.
86) MODLIN IM. Adaptation and renewal of the gastrointestinal surgeon to meet the continuous challenge of modern gastroenterology. Scand J Gastroenterol 1992; 27(Suppl 193):100-105.
87) Haque S, MODLIN IM, West AB. Multiple Glomus Tumors of the Stomach With Intravascular Spread. Am J of Surg Pathol 16(3): 291-299, 1992.
88) Leach SD, Gorelick FS, MODLIN IM. New perspectives on acute pancreatitis. Scand J Gastro 1992; 27(Suppl 192):29-38.
89) Basson MD, MODLIN IM, Flynn SD. Gastric stromal tumors: current clinical and pathological perspectives. Surg, Gynecol and Obstet 1992; 175(5):477-89.
90) Lewis J, Basson M, MODLIN IM. Surgical therapy in acute esophageal variceal hemorrhage. Dig Dis . Scarpignato C, MODLIN IM (Ed) Karger 1992; 10 (1):46-55.
91) Scarpignato C, MODLIN IM (eds). The management of esophageal varices: In Digestive Dis Suppl. Karger 1992; 10(1):1-2.
92) Soybel DI, MODLIN IM. Implications of sustained suppression of gastric acid secretion. Am J Surg 1992 June; 163(6):613-622.
93) Ahlman H, Wangberg B, Nilsson O, Grimelius L, Granerus G, MODLIN IM, Stenovist O, Schersten T. Aspects on diagnosis and treatment of the foregut carcinoid syndrome. Scand J Gastro 1992; 27:459-471.
94) Soybel DI, MODLIN IM. Sustained suppression of gastric secretion and the risk of neoplasia in the gastric mucosa. Am J Gastro 1991; 86(12):1713-1719.
95) Ballantyne GH, Savoca PE, Flannery JT, Ahlman H, MODLIN IM. Incidence and mortality of carcinoids of the colon: Data from the Connecticut Tumor Resistery. Cancer 1992; 69(10):2400-2405.
96) Hurst RD, MODLIN IM. Future prospects for somatostatin analogs. Cont Oncol 1991; 1(5):27-32.
97) Berkowitz I, Marks IN, MODLIN IM. Case report. Low acid, high gastrin-a signal sequence for gastric endocrine neoplasia? Eur J Gastro & Hepat 1991; 3:198-91.
98) Hurst RD, MODLIN IM. The therapeutic role of octreotide in the management of surgical disorders. Am J Surg 1991; 162(5):499-507.
99) Armstrong DN, Ballantyne GH, MODLIN IM. Erythromycin for reflex ileus in Ogilvie's syndrome. Lancet 1991; 337:338.
100) Ballantyne GH, Savoca PE, Flemming FX, Longo WE, MODLIN IM. Screening colonoscopy in asymptomatic patients. Diseases of the Colon & Rectum 1990;33:14.
101) Savoca PE, Ballantyne GH, Flannery JT, MODLIN IM. Mucinous rectal cancer in the state of Connecticut: 1982-1986. Diseases of the Colon & Rectum 1990; 33:13.
102) Ferrara A, Armstrong DN, Bjorck S, Ballantyne GH, MODLIN IM, McMillen MA. In-vitro immunosuppression by lidocaine: implications for the topical treatment of ulcerative colitis. Diseases of the Colon & Rectum 1990; 33:34-35.
103) Brophy CM, Ballantyne GH, MODLIN IM. Small bowel obstruction secondary to phytobezoar in the post gastrectomy patient. Contemp Surg 1990; 37:27-33.
104) Vukasin AP, Ballantyne GH, Flannery JH, Lerner E, MODLIN IM. Increasing incidence of cecal and sigmoid carcinoma: data from the Connecticut tumor registry. Cancer 1990; 66(I1):2442-2449.
105) Ferrara A, MacArthur JD, Wright HK, MODLIN IM, McMillen MA. Hypothermia and acidosis worsen coagulopathy in the massively transfused. Am J Surg 1990; 160(5):515-518.
106) Reilly JM, Ballantyne GH, Zdon MJ, Zucker KA, MODLIN IM. Evlauation of the occult blood test in screening for colorectal neoplasms: a prospective study utilizing flexible endoscopy. Am Surgeon 1990; 56:119-123.
107) Longo WE, Ballantyne GH, MODLIN IM. Colorectal disease in spinal cord patients: an occult diagnosis. Disease of the Colon & Rectum 1990; 33(2):131-134.
108) Savoca PE, Longo WE, Zucker KA, McMillen MA, MODLIN IM. The increasing prevalence of acalculous cholecystitis in outpatients: Results of a 7-year study. Ann Surg 1990; 211(4):433-437.
109) Leach S, Gorelick F, MODLIN IM. Acute Pancreatitis at Its Centenary: The Contribution of Reginald Fitz. Ann Surg 1990; 212(1):109-113.
110) Tierney R, Ballantyne G, MODLIN IM. The Adenoma to Carcinoma Sequence. Surg Gynecol & Obstet 1990; 171(1):81-94.
111) Bilchik A, Leach S, Zucker K, MODLIN IM. Experimental Models of Acute Pancreatitis. J Surg Research 1990; 48:639-647.
112) Wong TY, Enriquez RE, MODLIN IM, Soldano L, Ouellette GS, Kapadia CR. Recurrent Hemorrhage from an invaginated Meckel's diverticulum in a 78-year-old man. Am J or Gastroenterology 1990; 85:2.
113) Zucker ZA, Longo WE, MODLIN IM, Bilchik AJ, Adrian TE. Malignant diathesis from jejunal-ileal carcinoids. Am J Gastroenterol 1989; 84(2):182-186.
114) Longo WE, Baker CB, McMillen MA, MODLIN IM, Degutis LC, Zucker KA. Nonoperative management of adult blunt splenic trauma: Criteria for successful outcome. Ann Surg 1989; 210(5):626-629.
115) Longo WE, Zucker KA, Zdon MJ, MODLIN IM. Detection of early gastric cancer in an aggressive endoscopy unit. Am Surg 1989; 55 (2):100-104.
116) Longo WE, Ballantyne GH, MODLIN IM. The colon, anorectum and spinal cord patient. A review of the functional alterations of the denervated hindgut. Dis Col & Rect 1989; 32(3):261-267.
117) Brophy CM, Morris J, Sussman J, MODLIN IM. "Pseudoascites" secondary to an amylase-producing serous ovarian cystadenoma. J Clin Gastroenterol 1989; 11(6):703-706.
118) Ballantyne GH, MODLIN IM. Postoperative follow-up for colorectal cancer: Who are we kidding? J Clin Gastro 1988; 10(4):359-364.
119) Romano TJ, Graham SM, Chuong J, Ballantyne GH, MODLIN IM, Sussman J, West AB. Bleeding colonic ulcers secondary to atheromatous microemboli after left heart catheterization. J Clin Gastro 1988; 10(6):693-698.
120) Longo WE, Ballantyne GH, Bilchik AJ, MODLIN IM. Advanced rectal cancer. What is the best palliation? Dis Colon Rectum 1988; 31(II):842-847.
121) Longo WE, Ballantyne GH, MODLIN IM. Colonoscopic detection of early colorectal cancers: Impact of a surgical endoscopy service. Ann Surg 1988; 207: 174-178.
122) Longo WE, Zucker KA, Zdon MJ, MODLIN IM. Gastric cancer in Connecticut: Outlook for improved survival. Conn Med 1988; 52:3-6.
123) Rubin BG, Ballantyne GH, Zdon MJ, Zucker KA, MODLIN IM. The role of flexible sigmoidoscopy in the preoperative screening of patients with inguinal hernia. A high yield of neoplasms. Arch Surg 1987; 122:296-299.
124) Letsou G, Ballantyne GH, Zdon MJ, Zucker KA, MODLIN IM. Screening for colorectal neoplasms: A comparison of the fecal occult blood test and endoscopic examination. Dis Colon Rectum 1987; 30:839-843.
125) Cambria RP, Faust G, Gusberg R, Tilson MD, Zucker KA, MODLIN IM. Percutaneous angioplasty for peripheral arterial occlusive disease. Correlates of Clinical Success. Arch Surg 1987; 122:283-287.
126) Longo WE, Zucker KA, Zdon MJ, Ballantyne GH, Cambria RP, MODLIN IM. Role of endoscopy in the diagnosis of early gastric cancer. Arch Surg 1987; 122: 292-295.
127) Graham SM, Ballantyne GH, MODLIN IM. Gastric epithelioid leiomyomatous tumors: Review of the literature. Surg Gynecol Obstet 1987; 164:391-397.
128) Graham SM, Ballantyne GH, MODLIN IM. Gastric epithelioid leiomyosarcoma: A curable gastric neoplasm. Am J Gastroenterol 1987; 82:82-85.
129) Basson MD, MODLIN IM. Pepsinogen: Prolate ellipsoid or unrecognized pathogen? J Clin Gastroenterol 1987; 9(4): 75-479.
130) Ballantyne GH, Graham S, Hammers L, MODLIN IM. Superior mesenteric artery syndrome following ileal “J”-pouch anal anastomosis: An iatrogenic cause of early postoperative obstruction. Dis Colon Rectum 1987; 30:472-474.
131) Ballantyne GH, MODLIN IM. Advances of endoscopic therapy for gastric diseases. Problems in Gen Surg 1987; 4: 223-238.
132) Sumpio BE, Ballantyne GH, Zdon MJ, MODLIN IM. Perforated appendicitis and obstructing colonic carcinoma in the elderly. Dis Colon Rectum 1986; 29:668-670.
133) Longo WE, Ballantyne GH, Gerald WL, MODLIN IM. Squamous cell carcinoma in situ in condyloma accuminatum. Dis Colon Rectum 1986; 29:503-506.
134) Letsou G, Ballantyne GH, Zdon MJ, MODLIN IM. Rectal carcinoma in a renal transplant patient. Long term complication of immunosuppression? Dis Colon Rectum 1986; 29(2):133-135.
135) Peterson JM, McCallum RW, Gartman D, MODLIN IM. The medical and surgical approach to gastroesophageal reflux. Pract Gastroenterol 1985.
136) Letsou G, Ross P, Ballantyne GH, Zdon MJ, MODLIN IM. Flexible sigmoidoscopy versus stool guaiac as a screening test for lesions of the distal colon and rectum. Gastrointest Endosc 1985; 31(2):148.
137) MODLIN IM, Brennan MF. The diagnosis and management of gastrinoma. Surg Gynecol Obstet 1984; 158(1):97-104.
138) MODLIN IM, Jaffe BM, Sand A, Albert D. The early diagnosis of gastrinoma. Ann Surg 1982; 196(5): 512-517.
139) MODLIN IM. Carcinoid syndrome. J Clin Gastroenterol 1980; 2(4):349-354.
140) MODLIN IM. Endocrine tumors of the pancreas. Surg Gynecol Obstet 1979; 149(II):751-769.
141) MODLIN IM, Lamers CBH. Multiple endocrine neoplasia type II (Sipple's Syndrome). S Afr Med J 1979; 56(13): 521-525.
142) MODLIN IM, Lamers CBH. Multiple endocrine neoplasia type I (Wermer's Syndrome). S Afr Med J 1979; 56(12): 485-488.
143) MODLIN IM, Farndon JR, Sheperd A, Johnston IDA, Kennedy TL, Montgomery DAD, Welbourn RB. Phaeochromocytomas in 72 patients: Clinical and diagnostic features, treatment and long term results. Br J Surg 1979 July; 66(7):456-465.
144) MODLIN IM, Bloom SR, Mitchell S. VIP: the cause of the watery diarrhea syndrome. Adv Exp Med Biol 1978; (106):195-201.
145) Maempel FZ, MODLIN IM,. Diagnosis and management of gastric carcinoid tumours with hepatic metastases. Br J Surg 1978; 65(7):516-520.
146) Tarin D, Allison DJ, MODLIN IM, Neale G. Diagnosis and management of obscure gastrointestinal bleeding. Br Med J 1978 Sep; 2: 751-755.
147) MODLIN IM, Spencer J. Unilateral short thumb associated with bleeding duodenal reduplication. Br Med J 1978; 1(6110):412.
148) MODLIN IM, Bloom SR. VIPomas and the watery diarrhoea syndrome. S Afr J Med 1978 Jul; 54(2):53-56.
149) MODLIN IM, Bloom SR, Barnes A, Welbourn RB. Cure of intractable watery diarrhoea by excision of a vipoma. Br J Surg 1978; 65(4):234-236.
150) Allison DJ, MODLIN IM, Jenkins WJ. Treatment of carcinoid liver metastases by hepatic-artery embolization. Lancet 1977 Dec; 2(8052-8053):1323-1325.
151) MODLIN IM, Christofides N, Bloom SR. Plasma-motilin and carcinoid tumors. Lancet 1977, Nov; 2(8045):979.
152) McCloy RF, MODLIN IM. Cimetidine, pH and the Zollinger-Ellison Syndrome. Lancet 1977; 2(8048):1131-1132.
153) MODLIN IM, Bloom SR. Overdiagnosis of endocrine gut tumors. Lancet 1977 Jun; 1:1366.